Table 1 Demographic pattern and laboratory results of RA patients and controls
From: Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Parameters | RA patients | Controls | t-test | P value |
|---|---|---|---|---|
Number (F/M) | 120 (90/30) | 90 (60/30) | - | NS |
Age (years) | 41.33 ± 15.93 | 40.5 ± 17.5 | 0.36 | NS |
Duration of illness (years) | 9.65 ± 4.28 | 0.0 | - | - |
ESR (1st hr) mm/hr | 41.62 ± 8.02 | 8.65 ± 2.89 | 17.21 | 0.001* |
RF Mean ± SE (IU/mL) | (149.34 ± 64.30) | 13.5 ± 21 | 18.99 | 0.001* |
Anti-CCP-2 Ab Mean ± SE IU/mL | 62.54 ± 21.22 | 4.41 ± 1.20 | 19.85 | 0.001* |
PON-1 activity (nmol/min/ml) | 64.44 ± 11.33 | 152.18 ± 17.74 | 16.25 | 0.001* |
ARE activity (Um/l) | 197.65 ± 83.84 | 363.65 ± 169.15 | 10.52 | 0.001* |